z-logo
open-access-imgOpen Access
Complete remission of an oropharyngeal cancer to nivolumab even after immunotherapy discontinuation
Author(s) -
Manuel Stöth,
Thomas J. Meyer,
Matthias Scheich,
Stephan Hackenberg,
Agmal Scherzad
Publication year - 2020
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0040-1711037
Subject(s) - nivolumab , discontinuation , medicine , immunotherapy , oncology , complete remission , complete response , cancer , head and neck , quality of life (healthcare) , head and neck squamous cell carcinoma , basal cell , head and neck cancer , surgery , chemotherapy , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here